Dayyanah Sumodhee

Dayyanah Sumodhee

Auto-generated profile, based on publicly available information

Dayyanah Sumodhee

University College London Institute of Ophthalmology, London, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in Nature Machine Intelligence
Verified
Journal Article
Open access
PDF file
NPNikolas Pontikos
Nikolas Pontikos
WWWilliam A. Woof
William A. Woof
SLSiying Lin
Siying Lin
BGBiraja Ghoshal
Biraja Ghoshal
BMBernardo S. Mendes
Bernardo S. Mendes
MMMichel Michaelides
Michel Michaelides
Rare eye diseases such as inherited retinal diseases (IRDs) are challenging to diagnose genetically. IRDs are typically monogenic disorders and represent a leading cause of blindness in children and working-age adults worldwide. A growing number are now being targeted in clinical trials, with approved treatments increasingly available. However, access requires a genetic diagnosis to be established sufficiently early. Critically, the timely identification of a genetic cause remains challenging. We demonstrate that a deep learning algorithm, Eye2Gene, trained on a large multimodal imaging dataset of individuals with IRDs (n = 2,451) and externally validated on data provided by five different clinical centres, provides better-than-expert-level top-five accuracy of 83.9% for supporting genetic diagnosis for the 63 most common genetic causes. We demonstrate that Eye2Gene’s next-generation phenotyping can increase diagnostic yield by improving screening for IRDs, phenotype-driven variant prioritization and automatic similarity matching in phenotypic space to identify new genes. Eye2Gene is accessible online (app.eye2gene.com) for research purposes.

20 March 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
QNQuang Nguyen
Quang Nguyen
WWWilliam Woof
William Woof
NKNathaniel Kabiri
Nathaniel Kabiri
SSSagnik Sen
Sagnik Sen
MVMalena Daich Varela
Malena Daich Varela
NPNikolas Pontikos
Nikolas Pontikos
Introduction Inherited retinal diseases (IRD) are a leading cause of visual impairment and blindness in the working age population. Mutations in over 300 genes have been found to be associated with IRDs and identifying the affected gene in patients by molecular genetic testing is the first step towards effective care and patient management. However, genetic diagnosis is currently slow, expensive and not widely accessible. The aim of the current project is to address the evidence gap in IRD diagnosis with an AI algorithm, Eye2Gene, to accelerate and democratise the IRD diagnosis service. Methods and analysis The data-only retrospective cohort study involves a target sample size of 10 000 participants, which has been derived based on the number of participants with IRD at three leading UK eye hospitals: Moorfields Eye Hospital (MEH), Oxford University Hospital (OUH) and Liverpool University Hospital (LUH), as well as a Japanese hospital, the Tokyo Medical Centre (TMC). Eye2Gene aims to predict causative genes from retinal images of patients with a diagnosis of IRD. For this purpose, 36 most common causative IRD genes have been selected to develop a training dataset for the software to have enough examples for training and validation for detection of each gene. The Eye2Gene algorithm is composed of multiple deep convolutional neural networks, which will be trained on MEH IRD datasets, and externally validated on OUH, LUH and TMC. Ethics and dissemination This research was approved by the IRB and the UK Health Research Authority (Research Ethics Committee reference 22/WA/0049) ‘Eye2Gene: accelerating the diagnosis of IRDs’ Integrated Research Application System (IRAS) project ID: 242050. All research adhered to the tenets of the Declaration of Helsinki. Findings will be reported in an open-access format.

12 November 2024 in Ophthalmology Science
Verified
Journal Article
Open access
WWWilliam A. Woof
William A. Woof
TGThales A.C. de Guimarães
Thales A.C. de Guimarães
SASaoud Al-khuzaei
Saoud Al-khuzaei
MVMalena Daich Varela
Malena Daich Varela
SSSagnik Sen
Sagnik Sen
NPNikolas Pontikos
Nikolas Pontikos
To quantify relevant fundus autofluorescence (FAF) features cross-sectionally and longitudinally in a large cohort of patients with inherited retinal diseases (IRDs). Retrospective study of imaging data. Patients with a clinical and molecularly confirmed diagnosis of IRD who have undergone 55° FAF imaging at Moorfields Eye Hospital (MEH) and the Royal Liverpool Hospital between 2004 and 2019. Five FAF features of interest were defined: vessels, optic disc, perimacular ring of increased signal (ring), relative hypo-autofluorescence (hypo-AF), and hyper-autofluorescence (hyper-AF). Features were manually annotated by 6 graders in a subset of patients based on a defined grading protocol to produce segmentation masks to train an artificial intelligence model, AIRDetect, which was then applied to the entire imaging data set. Quantitative FAF features, including area and vessel metrics, were analyzed cross-sectionally by gene and age, and longitudinally. AIRDetect feature segmentation and detection were validated with Dice score and precision/recall, respectively. A total of 45 749 FAF images from 3606 patients with IRD from MEH covering 170 genes were automatically segmented using AIRDetect. Model-grader Dice scores for the disc, hypo-AF, hyper-AF, ring, and vessels were, respectively, 0.86, 0.72, 0.69, 0.68, and 0.65. Across patients at presentation, the 5 genes with the largest hypo-AF areas were CHM, ABCC6, RDH12, ABCA4, and RPE65, with mean per-patient areas of 43.72, 29.57, 20.07, 19.65, and 16.92 mm2, respectively. The 5 genes with the largest hyper-AF areas were BEST1, CDH23, NR2E3, MYO7A, and RDH12, with mean areas of 0.50, 047, 0.44, 0.38, and 0.33 mm2, respectively. The 5 genes with the largest ring areas were NR2E3, CDH23, CRX, EYS, and PDE6B, with mean areas of 3.60, 2.90, 2.89, 2.56, and 2.20 mm2, respectively. Vessel density was found to be highest in EFEMP1, BEST1, TIMP3, RS1, and PRPH2 (11.0%, 10.4%, 10.1%, 10.1%, 9.2%) and was lower in retinitis pigmentosa (RP) and Leber congenital amaurosis genes. Longitudinal analysis of decreasing ring area in 4 RP genes (RPGR, USH2A, RHO, and EYS) found EYS to be the fastest progressor at −0.178 mm2/year. We have conducted the first large-scale cross-sectional and longitudinal quantitative analysis of FAF features across a diverse range of IRDs using a novel AI approach. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

10 July 2023 in Nicotine & Tobacco Research
Verified
Journal Article
Open access
PDF file
DSDayyanah Sumodhee
Dayyanah Sumodhee
HWHannah Walsh
Hannah Walsh
LBLeonie Brose
Leonie Brose
AMAnn Mcneill
Ann Mcneill
AMAndy McEwen
Andy McEwen
MDMaría Duaso
María Duaso
Co-use of tobacco and cannabis is highly prevalent among cannabis users and is associated with poorer tobacco cessation outcomes. This study explored the barriers and enablers influencing stop-smoking practitioners’ ability to provide optimal support to co-users. Online semi-structured interviews were audio recorded. Interviewees (n = 20) were UK-based certified stop-smoking practitioners. An interview schedule informed by the “capability”, “opportunity”, “motivation” (COM-B) model was designed to explore participants’ perceived barriers and enablers in better supporting co-users to achieve abstinence of both substances or tobacco harm reduction. The transcripts were analyzed using framework analysis. Capability: Practitioners’ lack of knowledge and skills undermines their delivery of smoking cessation interventions to co-users. Interestingly, when cannabis is used for medicinal reasons, practitioners feel unable to provide adequate support. Opportunity: Service recording systems play an important role in screening for co-use and supporting co-users. When responding to clients’ specific needs and practitioners’ uncertainties, a positive therapeutic relationship and a support network of peers and other healthcare professionals are needed. Motivation: supporting co-users is generally perceived as part of practitioners’ roles but there are concerns that co-users are less likely to successfully stop smoking. Practitioners are willing to support co-users, but their lack of knowledge and access to an appropriate recording system are barriers to doing so. Having a supportive team and a positive therapeutic relationship is perceived as important. Identified barriers can be mostly addressed with further training to improve tobacco cessation outcomes for co-users.

10 July 2016 in Journal of Health Psychology
Verified
Journal Article
Closed access
DSDayyanah Sumodhee
Dayyanah Sumodhee
NPNicola Payne
Nicola Payne
This study examined the possible intergenerational transmission of eating beliefs and intentions between 60 mothers and their adult children. Maternal restrictive feeding practices were correlated with mothers’ own healthy eating attitudes and subjective norms, and with their adult children’s subjective norms. Mothers’ beliefs and intentions were correlated with their adult children. Adult children’s intentions to eat healthily were predicted by their attitudes and perceived behavioural control, and also by their mothers’ intentions and perceived behavioural control. Mothers’ own beliefs and intentions may be involved in shaping their children’s beliefs and intentions into adulthood but their child feeding practices may have less of an influence.

9 May 2025 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
WWWENDY WONG
WENDY WONG
DSDayyanah Sumodhee
Dayyanah Sumodhee
TMTiyi Morris
Tiyi Morris
BTBhavna Tailor
Bhavna Tailor
CHCatherine Hollyhead
Catherine Hollyhead
NPNikolas Pontikos
Nikolas Pontikos
Background Inherited retinal diseases (IRDs) are the leading cause of blindness in young people in the UK. Despite significant improvements in genomics medicine, the diagnosis of these conditions remains challenging, and around 40% do not receive a definite genetic diagnosis after extensive genetic testing. This survey aims to investigate the experience of individuals affected by IRDs, their relatives, friends and caregivers, focusing on their care and diagnostic journey. Additionally, it explores the potential acceptability of artificial intelligence (AI) technologies, such as Eye2Gene, that predict causative genes from retinal images of patients with IRDs. Methods This cross-sectional survey included Likert scale and open-ended questions and was distributed electronically using the Qualtrics platform between April and August 2024. The survey included questions on respondent demographics; their journey to receive specialist care and genetic testing; their information needs and their attitude towards AI-augmented diagnosis. Descriptive statistics and content analysis were used to interpret the survey responses. Results The survey had 247 responses, of which 242 were analysed after removing four duplicates and one without consent; 80.2% were patients and the remainder were relatives, friends or caregivers. There was substantial variability in patient diagnostic journeys in terms of waiting times to see a specialist (IQR, 1–4 years), commute required (IQR, 10–74 miles) and number of visits to reach a diagnosis (IQR, 2–4). A substantial proportion of patients (35.8%) had a change in diagnosis. The majority of respondents (>90%) were overwhelmingly in favour of the integration of AI into the IRD pathway to accelerate genetic diagnosis and improve care. Conclusion This survey identifies several key gaps and disparities in the IRD care pathway which may potentially be bridged with AI. The survey also reveals a favourable attitude towards incorporating AI into diagnostic testing of IRDs.